The dengue virus non-structural 1 protein: risks and benefits


Autoria(s): Santos, Jaime Henrique Amorim; Alves, Rúbens Prince dos Santos; Boscardin, Silvia Beatriz; Ferreira, Luis Carlos de Souza
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

22/04/2014

22/04/2014

06/06/2014

Resumo

The dengue virus (DENV) non-structural 1 (NS1) protein plays a critical role in viral RNA replication and has a central position in DENV pathogenesis. DENV NS1 is a glycoprotein expressed in infected mammalian cells as soluble monomers that dimerize in the lumen of the endoplasmic reticulum; NS1 is subsequently transported to the cell surface, where it remains membrane associated or is secreted into the extracellular milieu as a hexameric complex. During the last three decades, the DENV NS1 protein has also been intensively investigated as a potential target for vaccines and antiviral drugs. In addition, NS1 is the major diagnostic marker for dengue infection. This review highlights some important issues regarding the role of NS1 in DENV pathogenesis and its biotechnological applications, both as a target for the development of safe and effective vaccines and antiviral drugs and as a tool for the generation of accurate diagnostic methods

FAPESP, 2011/51.761-6

FAPESP, 2007/08648-8

CNPq, INCTV 15203*8

CNPq, INCTV 15203*12

Identificador

Virus Research, Amsterdam, v.181, p.53-60, 2014

http://www.producao.usp.br/handle/BDPI/44581

10.1016/j.virusres.2014.01.001

http://dx.doi.org/10.1016/j.virusres.2014.01.001

Idioma(s)

eng

Publicador

Elsevier Science

Amsterdam

Relação

Virus Research

Direitos

restrictedAccess

Elsevier B.V.

Palavras-Chave #Dengue virus #NS1 protein #Pathogenesis #Antiviral #Vaccine #Diagnosis #VÍRUS #DENGUE #PROTEÍNAS #VACINAS #DIAGNÓSTICO
Tipo

article

original article

publishedVersion